Report Detail
Global Recombinant Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4675464 |
- 20 February, 2026 |
- Global |
- 105 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Recombinant Monoclonal Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Recombinant Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Monoclonal Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Monoclonal Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological, Enzo Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Monoclonal Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Humanized Antibodies
Small Molecule Antibody
Other
Market segment by Application
Immunohistochemistry
Western Blot
Immunofluorescence
Other
Major players covered
Abcam
Boster Bio
Evitria
Novus Biologicals
ACROBiosystems
Abyntek Biopharma
Sino Biological
Enzo Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Recombinant Monoclonal Antibody from 2021 to 2026.
Chapter 3, the Recombinant Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Monoclonal Antibody.
Chapter 14 and 15, to describe Recombinant Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Monoclonal Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Humanized Antibodies
- 1.3.3 Small Molecule Antibody
- 1.3.4 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Monoclonal Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Immunohistochemistry
- 1.4.3 Western Blot
- 1.4.4 Immunofluorescence
- 1.4.5 Other
- 1.5 Global Recombinant Monoclonal Antibody Market Size & Forecast
- 1.5.1 Global Recombinant Monoclonal Antibody Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Recombinant Monoclonal Antibody Sales Quantity (2021-2032)
- 1.5.3 Global Recombinant Monoclonal Antibody Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Abcam
- 2.1.1 Abcam Details
- 2.1.2 Abcam Major Business
- 2.1.3 Abcam Recombinant Monoclonal Antibody Product and Services
- 2.1.4 Abcam Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Abcam Recent Developments/Updates
- 2.2 Boster Bio
- 2.2.1 Boster Bio Details
- 2.2.2 Boster Bio Major Business
- 2.2.3 Boster Bio Recombinant Monoclonal Antibody Product and Services
- 2.2.4 Boster Bio Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Boster Bio Recent Developments/Updates
- 2.3 Evitria
- 2.3.1 Evitria Details
- 2.3.2 Evitria Major Business
- 2.3.3 Evitria Recombinant Monoclonal Antibody Product and Services
- 2.3.4 Evitria Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Evitria Recent Developments/Updates
- 2.4 Novus Biologicals
- 2.4.1 Novus Biologicals Details
- 2.4.2 Novus Biologicals Major Business
- 2.4.3 Novus Biologicals Recombinant Monoclonal Antibody Product and Services
- 2.4.4 Novus Biologicals Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Novus Biologicals Recent Developments/Updates
- 2.5 ACROBiosystems
- 2.5.1 ACROBiosystems Details
- 2.5.2 ACROBiosystems Major Business
- 2.5.3 ACROBiosystems Recombinant Monoclonal Antibody Product and Services
- 2.5.4 ACROBiosystems Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 ACROBiosystems Recent Developments/Updates
- 2.6 Abyntek Biopharma
- 2.6.1 Abyntek Biopharma Details
- 2.6.2 Abyntek Biopharma Major Business
- 2.6.3 Abyntek Biopharma Recombinant Monoclonal Antibody Product and Services
- 2.6.4 Abyntek Biopharma Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Abyntek Biopharma Recent Developments/Updates
- 2.7 Sino Biological
- 2.7.1 Sino Biological Details
- 2.7.2 Sino Biological Major Business
- 2.7.3 Sino Biological Recombinant Monoclonal Antibody Product and Services
- 2.7.4 Sino Biological Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Sino Biological Recent Developments/Updates
- 2.8 Enzo Life Sciences
- 2.8.1 Enzo Life Sciences Details
- 2.8.2 Enzo Life Sciences Major Business
- 2.8.3 Enzo Life Sciences Recombinant Monoclonal Antibody Product and Services
- 2.8.4 Enzo Life Sciences Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Enzo Life Sciences Recent Developments/Updates
3 Competitive Environment: Recombinant Monoclonal Antibody by Manufacturer
- 3.1 Global Recombinant Monoclonal Antibody Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Recombinant Monoclonal Antibody Revenue by Manufacturer (2021-2026)
- 3.3 Global Recombinant Monoclonal Antibody Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Recombinant Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Recombinant Monoclonal Antibody Manufacturer Market Share in 2025
- 3.4.3 Top 6 Recombinant Monoclonal Antibody Manufacturer Market Share in 2025
- 3.5 Recombinant Monoclonal Antibody Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Monoclonal Antibody Market: Region Footprint
- 3.5.2 Recombinant Monoclonal Antibody Market: Company Product Type Footprint
- 3.5.3 Recombinant Monoclonal Antibody Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Recombinant Monoclonal Antibody Market Size by Region
- 4.1.1 Global Recombinant Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 4.1.2 Global Recombinant Monoclonal Antibody Consumption Value by Region (2021-2032)
- 4.1.3 Global Recombinant Monoclonal Antibody Average Price by Region (2021-2032)
- 4.2 North America Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.3 Europe Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.4 Asia-Pacific Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.5 South America Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.6 Middle East & Africa Recombinant Monoclonal Antibody Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 5.2 Global Recombinant Monoclonal Antibody Consumption Value by Type (2021-2032)
- 5.3 Global Recombinant Monoclonal Antibody Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 6.2 Global Recombinant Monoclonal Antibody Consumption Value by Application (2021-2032)
- 6.3 Global Recombinant Monoclonal Antibody Average Price by Application (2021-2032)
7 North America
- 7.1 North America Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 7.2 North America Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 7.3 North America Recombinant Monoclonal Antibody Market Size by Country
- 7.3.1 North America Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 7.3.2 North America Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 8.2 Europe Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 8.3 Europe Recombinant Monoclonal Antibody Market Size by Country
- 8.3.1 Europe Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Recombinant Monoclonal Antibody Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Recombinant Monoclonal Antibody Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 10.2 South America Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 10.3 South America Recombinant Monoclonal Antibody Market Size by Country
- 10.3.1 South America Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 10.3.2 South America Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Recombinant Monoclonal Antibody Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Recombinant Monoclonal Antibody Market Drivers
- 12.2 Recombinant Monoclonal Antibody Market Restraints
- 12.3 Recombinant Monoclonal Antibody Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Recombinant Monoclonal Antibody and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Recombinant Monoclonal Antibody
- 13.3 Recombinant Monoclonal Antibody Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Recombinant Monoclonal Antibody Typical Distributors
- 14.3 Recombinant Monoclonal Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Recombinant Monoclonal Antibody. Industry analysis & Market Report on Recombinant Monoclonal Antibody is a syndicated market report, published as Global Recombinant Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Recombinant Monoclonal Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
